View in EDS HTML Full Text PDF Full Text

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults.

Saved in:
Bibliographic Details
Title: Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults.
Authors: Murdoch L; Emeritus Research, Camberwell, VIC, Australia., Quan K; Vaccine Clinical Research and Development, Pfizer Australia Pty Ltd, Sydney, NSW, Australia. Karen.Quan@pfizer.com., Baber JA; Vaccine Clinical Research and Development, Pfizer Australia Pty Ltd, Sydney, NSW, Australia., Ho AWY; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA., Zhang Y; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA., Xu X; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA., Lu C; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Cooper D; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Koury K; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Lockhart SP; Vaccine Research and Development, Pfizer Ltd, Hurley, UK., Anderson AS; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Türeci Ö; BioNTech, Mainz, Germany., Şahin U; BioNTech, Mainz, Germany., Swanson KA; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Gruber WC; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Kitchin N; Vaccine Research and Development, Pfizer Ltd, Hurley, UK.
Corporate Authors: C4591030 Clinical Trial Group
Source: Infectious diseases and therapy [Infect Dis Ther] 2023 Sep; Vol. 12 (9), pp. 2241-2258. Date of Electronic Publication: 2023 Sep 12.
Publication Type: Journal Article
Journal Info: Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37698774
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Murdoch+L%22">Murdoch L</searchLink>; Emeritus Research, Camberwell, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Quan+K%22">Quan K</searchLink>; Vaccine Clinical Research and Development, Pfizer Australia Pty Ltd, Sydney, NSW, Australia. Karen.Quan@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Baber+JA%22">Baber JA</searchLink>; Vaccine Clinical Research and Development, Pfizer Australia Pty Ltd, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Ho+AWY%22">Ho AWY</searchLink>; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Xu+X%22">Xu X</searchLink>; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lu+C%22">Lu C</searchLink>; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Cooper+D%22">Cooper D</searchLink>; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Koury+K%22">Koury K</searchLink>; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lockhart+SP%22">Lockhart SP</searchLink>; Vaccine Research and Development, Pfizer Ltd, Hurley, UK.<br /><searchLink fieldCode="AU" term="%22Anderson+AS%22">Anderson AS</searchLink>; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Türeci+Ö%22">Türeci Ö</searchLink>; BioNTech, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Şahin+U%22">Şahin U</searchLink>; BioNTech, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Swanson+KA%22">Swanson KA</searchLink>; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Gruber+WC%22">Gruber WC</searchLink>; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.<br /><searchLink fieldCode="AU" term="%22Kitchin+N%22">Kitchin N</searchLink>; Vaccine Research and Development, Pfizer Ltd, Hurley, UK.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22C4591030+Clinical+Trial+Group%22">C4591030 Clinical Trial Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101634499%22">Infectious diseases and therapy</searchLink> [Infect Dis Ther] 2023 Sep; Vol. 12 (9), pp. 2241-2258. <i>Date of Electronic Publication: </i>2023 Sep 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%22">Adis </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101634499 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8229 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221936382%22">21936382 </searchLink><i>NLM ISO Abbreviation: </i>Infect Dis Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37698774
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40121-023-00863-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2241
    Titles:
      – TitleFull: Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Murdoch L
      – PersonEntity:
          Name:
            NameFull: Quan K
      – PersonEntity:
          Name:
            NameFull: Baber JA
      – PersonEntity:
          Name:
            NameFull: Ho AWY
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Xu X
      – PersonEntity:
          Name:
            NameFull: Lu C
      – PersonEntity:
          Name:
            NameFull: Cooper D
      – PersonEntity:
          Name:
            NameFull: Koury K
      – PersonEntity:
          Name:
            NameFull: Lockhart SP
      – PersonEntity:
          Name:
            NameFull: Anderson AS
      – PersonEntity:
          Name:
            NameFull: Türeci Ö
      – PersonEntity:
          Name:
            NameFull: Şahin U
      – PersonEntity:
          Name:
            NameFull: Swanson KA
      – PersonEntity:
          Name:
            NameFull: Gruber WC
      – PersonEntity:
          Name:
            NameFull: Kitchin N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2023 Sep
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2193-8229
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Infectious diseases and therapy
              Type: main
ResultId 1